ResearcherArmy Medical UniversityActive in the last 2 years
Tao Peng
Matched on ORCID iD 0000-0002-5779-3377; OpenAlex author ID A5024834531. Sources: OpenAlex.
Their work
- Papers
- 13 (first author 0, last author 7)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 35
2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 3 papers · 2022: 2 papers · 2023: 2 papers · 2024: 1 paper
Papers 13
- Single-cell and spatial transcriptomic analyses reveal the cellular origins and drivers of liver metastasis from pancreatic cancer Last author DOI 10.21203/rs.3.rs-4128922/v1↗
- miR-222-3p-containing macrophage-derived extracellular vesicles confer gemcitabine resistance via TSC1-mediated mTOR/AKT/PI3K pathway in pancreatic cancer. Last author DOI 10.1007/s10565-022-09736-y↗
- USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2. Last author DOI 10.1016/j.biopha.2023.115359↗
- Nerve Growth Factor (NGF) Encourages the Neuroinvasive Potential of Pancreatic Cancer Cells by Activating the Warburg Effect and Promoting Tumor Derived Exosom… Co-author DOI 10.1155/2022/8445093↗
- Tumor Cell Derived Exosomal GOT1 Suppresses Tumor Cell Ferroptosis to Accelerate Pancreatic Cancer Progression by Activating Nrf2/HO-1 Axis via Upregulating CC… Last author DOI 10.3390/cells11233893↗
- Circ-MBOAT2 knockdown represses tumor progression and glutamine catabolism by miR-433-3p/GOT1 axis in pancreatic cancer. Co-author DOI 10.1186/s13046-021-01894-x↗
- Up-Regulation of circEIF6 Contributes to Pancreatic Cancer Development Through Targeting miR-557/SLC7A11/PI3K/AKT Signaling. Last author DOI 10.2147/cmar.s280307↗
- Long Non-coding RNA DLEU2L Targets miR-210-3p to Suppress Gemcitabine Resistance in Pancreatic Cancer Cells via BRCA2 Regulation. Last author DOI 10.3389/fmolb.2021.645365↗
- Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210. Last author DOI 10.1007/s13402-019-00476-6↗
- Integration of transcriptome and cistrome analysis identifies RUNX1-target genes involved in pancreatic cancer proliferation. Co-author DOI 10.1016/j.ygeno.2020.11.010↗
- Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2018.04.035↗
- Everolimus Inhibits Growth of Gemcitabine-Resistant Pancreatic Cancer Cells via Induction of Caspase-Dependent Apoptosis and G2 /M Arrest. Co-author DOI 10.1002/jcb.25921↗
- Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness. Co-author DOI 10.1038/s41598-017-06132-z↗
Closest collaborators
The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Heshui Wu · 5 shared papers, 2017–2023 · strength 0.77
- Paper miR-222-3p-containing macrophage-derived extracellular vesicles confer gemcitabine resistance via TSC1-mediated mTOR/AK… DOI 10.1007/s10565-022-09736-y↗
- Paper Long Non-coding RNA DLEU2L Targets miR-210-3p to Suppress Gemcitabine Resistance in Pancreatic Cancer Cells via BRCA2 R… DOI 10.3389/fmolb.2021.645365↗
- Paper Circ-MBOAT2 knockdown represses tumor progression and glutamine catabolism by miR-433-3p/GOT1 axis in pancreatic cancer. DOI 10.1186/s13046-021-01894-x↗
- Shanmiao Gou · 3 shared papers, 2022–2023 · strength 0.59
- Paper miR-222-3p-containing macrophage-derived extracellular vesicles confer gemcitabine resistance via TSC1-mediated mTOR/AK… DOI 10.1007/s10565-022-09736-y↗
- Paper USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2. DOI 10.1016/j.biopha.2023.115359↗
- Paper Tumor Cell Derived Exosomal GOT1 Suppresses Tumor Cell Ferroptosis to Accelerate Pancreatic Cancer Progression by Activ… DOI 10.3390/cells11233893↗
- Yao Guo · 3 shared papers, 2021–2024 · strength 0.55
- Paper Single-cell and spatial transcriptomic analyses reveal the cellular origins and drivers of liver metastasis from pancre… DOI 10.21203/rs.3.rs-4128922/v1↗
- Paper USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2. DOI 10.1016/j.biopha.2023.115359↗
- Paper Circ-MBOAT2 knockdown represses tumor progression and glutamine catabolism by miR-433-3p/GOT1 axis in pancreatic cancer. DOI 10.1186/s13046-021-01894-x↗
- Jing Cui · 2 shared papers, 2023–2024 · strength 0.40
- Paper Single-cell and spatial transcriptomic analyses reveal the cellular origins and drivers of liver metastasis from pancre… DOI 10.21203/rs.3.rs-4128922/v1↗
- Paper USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2. DOI 10.1016/j.biopha.2023.115359↗
- Jing Cui · 2 shared papers, 2022–2023 · strength 0.39
- Paper miR-222-3p-containing macrophage-derived extracellular vesicles confer gemcitabine resistance via TSC1-mediated mTOR/AK… DOI 10.1007/s10565-022-09736-y↗
- Paper Nerve Growth Factor (NGF) Encourages the Neuroinvasive Potential of Pancreatic Cancer Cells by Activating the Warburg E… DOI 10.1155/2022/8445093↗
- Yao Guo · 2 shared papers, 2022–2023 · strength 0.39
- Paper miR-222-3p-containing macrophage-derived extracellular vesicles confer gemcitabine resistance via TSC1-mediated mTOR/AK… DOI 10.1007/s10565-022-09736-y↗
- Paper Nerve Growth Factor (NGF) Encourages the Neuroinvasive Potential of Pancreatic Cancer Cells by Activating the Warburg E… DOI 10.1155/2022/8445093↗
- Taoyu Chen · 2 shared papers, 2022–2024 · strength 0.38
- Paper Single-cell and spatial transcriptomic analyses reveal the cellular origins and drivers of liver metastasis from pancre… DOI 10.21203/rs.3.rs-4128922/v1↗
- Paper Tumor Cell Derived Exosomal GOT1 Suppresses Tumor Cell Ferroptosis to Accelerate Pancreatic Cancer Progression by Activ… DOI 10.3390/cells11233893↗
- Jing Cui · 2 shared papers, 2021–2022 · strength 0.32
- Paper Tumor Cell Derived Exosomal GOT1 Suppresses Tumor Cell Ferroptosis to Accelerate Pancreatic Cancer Progression by Activ… DOI 10.3390/cells11233893↗
- Paper Circ-MBOAT2 knockdown represses tumor progression and glutamine catabolism by miR-433-3p/GOT1 axis in pancreatic cancer. DOI 10.1186/s13046-021-01894-x↗
- Tao Yin · 1 shared paper, 2024 · strength 0.21
- Jingyuan Zhao · 1 shared paper, 2024 · strength 0.21
- Tao Yin · 1 shared paper, 2023 · strength 0.19
- Fei Xu · 1 shared paper, 2021 · strength 0.19
- Tiequan Zhang · 1 shared paper, 2021 · strength 0.19
- Yao Guo · 1 shared paper, 2022 · strength 0.17
- Xiaoxiao Zhou · 1 shared paper, 2021 · strength 0.15
- Q. Ping Dou · 1 shared paper, 2017 · strength 0.15
- Zhiyong Yang · 1 shared paper, 2020 · strength 0.13
- Xianxing Wang · 1 shared paper, 2020 · strength 0.10
- Fuming Xie · 1 shared paper, 2020 · strength 0.10
- Yongsheng Ouyang · 1 shared paper, 2020 · strength 0.10
- Yunchao Wang · 1 shared paper, 2020 · strength 0.10
- Junfeng Zhang · 1 shared paper, 2020 · strength 0.10
- Xuejun Xu · 1 shared paper, 2020 · strength 0.10
- Shixiang Guo · 1 shared paper, 2020 · strength 0.10
- Songsong Liu · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.